On the antioxidant properties of kynurenic acid: free radical scavenging activity and inhibition of oxidative stress
- PMID: 21763768
- DOI: 10.1016/j.ntt.2011.07.002
On the antioxidant properties of kynurenic acid: free radical scavenging activity and inhibition of oxidative stress
Abstract
Kynurenic acid (KYNA) is an endogenous metabolite of the kynurenine pathway for tryptophan degradation and an antagonist of both N-methyl-D-aspartate (NMDA) and alpha-7 nicotinic acetylcholine (α7nACh) receptors. KYNA has also been shown to scavenge hydroxyl radicals (OH) under controlled conditions of free radical production. In this work we evaluated the ability of KYNA to scavenge superoxide anion (O(2)(-)) and peroxynitrite (ONOO(-)). The scavenging ability of KYNA (expressed as IC(50) values) was as follows: OH=O(2)(-)>ONOO(-). In parallel, the antiperoxidative and scavenging capacities of KYNA (0-150 μM) were tested in cerebellum and forebrain homogenates exposed to 5 μM FeSO(4) and 2.5 mM 3-nitropropionic acid (3-NPA). Both FeSO(4) and 3-NPA increased lipid peroxidation (LP) and ROS formation in a significant manner in these preparations, whereas KYNA significantly reduced these markers. Reactive oxygen species (ROS) formation were determined in the presence of FeSO(4) and/or KYNA (0-100 μM), both at intra and extracellular levels. An increase in ROS formation was induced by FeSO(4) in forebrain and cerebellum in a time-dependent manner, and KYNA reduced this effect in a concentration-dependent manner. To further know whether the effect of KYNA on oxidative stress is independent of NMDA and nicotinic receptors, we also tested KYNA (0-100 μM) in a biological preparation free of these receptors - defolliculated Xenopus laevis oocytes - incubated with FeSO(4) for 1 h. A 3-fold increase in LP and a 2-fold increase in ROS formation were seen after exposure to FeSO(4), whereas KYNA attenuated these effects in a concentration-dependent manner. In addition, the in vivo formation of OH evoked by an acute infusion of FeSO(4) (100 μM) in the rat striatum was estimated by microdialysis and challenged by a topic infusion of KYNA (1 μM). FeSO(4) increased the striatal OH production, while KYNA mitigated this effect. Altogether, these data strongly suggest that KYNA, in addition to be a well-known antagonist acting on nicotinic and NMDA receptors, can be considered as a potential endogenous antioxidant.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
Resistance to kynurenic acid of the NMDA receptor-dependent toxicity of 3-nitropropionic acid and cyanide in cerebellar granule neurons.Brain Res. 2008 Jun 18;1215:200-7. doi: 10.1016/j.brainres.2008.04.013. Epub 2008 Apr 16. Brain Res. 2008. PMID: 18486115
-
Trolox ameliorates 3-nitropropionic acid-induced neurotoxicity in rats.Neurotoxicol Teratol. 2010 Mar-Apr;32(2):226-33. doi: 10.1016/j.ntt.2009.09.003. Epub 2009 Sep 13. Neurotoxicol Teratol. 2010. PMID: 19755148
-
Kynurenic acid, by targeting α7 nicotinic acetylcholine receptors, modulates extracellular GABA levels in the rat striatum in vivo.Eur J Neurosci. 2013 May;37(9):1470-7. doi: 10.1111/ejn.12160. Epub 2013 Feb 26. Eur J Neurosci. 2013. PMID: 23442092
-
Scavenging of reactive oxygen species by tryptophan metabolites helps Pseudomonas aeruginosa escape neutrophil killing.Free Radic Biol Med. 2014 Aug;73:400-10. doi: 10.1016/j.freeradbiomed.2014.06.003. Epub 2014 Jun 12. Free Radic Biol Med. 2014. PMID: 24929180 Review.
-
Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders.CNS Drugs. 2009;23(2):91-101. doi: 10.2165/00023210-200923020-00001. CNS Drugs. 2009. PMID: 19173370 Review.
Cited by
-
Kynurenines and Inflammation: A Remarkable Axis for Multiple Sclerosis Treatment.Pharmaceuticals (Basel). 2024 Jul 25;17(8):983. doi: 10.3390/ph17080983. Pharmaceuticals (Basel). 2024. PMID: 39204088 Free PMC article. Review.
-
Enzymatic transamination of D-kynurenine generates kynurenic acid in rat and human brain.J Neurochem. 2012 Mar;120(6):1026-35. doi: 10.1111/j.1471-4159.2012.07653.x. Epub 2012 Feb 2. J Neurochem. 2012. PMID: 22224417 Free PMC article.
-
Kynurenic Acid Acts as a Signaling Molecule Regulating Energy Expenditure and Is Closely Associated With Metabolic Diseases.Front Endocrinol (Lausanne). 2022 Feb 24;13:847611. doi: 10.3389/fendo.2022.847611. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35282457 Free PMC article. Review.
-
Low Serum Tryptophan Levels as an Indicator of Global Cognitive Performance in Nondemented Women over 50 Years of Age.Oxid Med Cell Longev. 2018 Nov 21;2018:8604718. doi: 10.1155/2018/8604718. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 30584466 Free PMC article.
-
Characterization of Redox Environment and Tryptophan Catabolism through Kynurenine Pathway in Military Divers' and Swimmers' Serum Samples.Antioxidants (Basel). 2022 Jun 22;11(7):1223. doi: 10.3390/antiox11071223. Antioxidants (Basel). 2022. PMID: 35883715 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical